TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/30/2023
Back to search
Official data from USPTO
CEDLARA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
07/08/2023
Trademark type
Word
Nice classes
42
Filing date
10/19/2020
Registration date
02/15/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/15/2022
Last transaction
07/08/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2020-08-00
First use in commerce
2020-08-00
Drawing code
4
Owner type
03
Owner location
Raleigh, NC
Examiner
SHANOSKI,JOANNA MARIE
Law office
O30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
9 Meters Biopharma, Inc.
Representatives
Devon E. White WYRICK ROBBINS YATES & PONTON LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Pharmaceutical research and development services; medical and scientific research information in the field of novel pharmaceutical discovery and development; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and scientific researchconducting clinical trials for others of new therapeutic entities (NTEs) defined as pharmacological treatments based on molecules that are already approved for other indications that are neither new chemical entities (NCEs) nor generics and new chemical entities (NCEs) and biologic license application (BLAs) as novel pharmaceutical treatments; research and development in the field of new therapeutic entities (NTEs) defined as pharmacological treatments based on molecules that are already approved for other indications that are neither new chemical entities (NCEs) nor generics and new chemical entities (NCEs) and biologic license application (BLAs) as novel pharmaceutical treatments; research and development in the field of novel pharmaceutical treatments and clinical trials; providing medical and scientific research information in the field of novel pharmaceutical treatments and clinical trials; clinical trials services for others; all of the foregoing related to celiac disease
Publications
History of USPTO decisions and trademark events.
23 publications found
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/30/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/30/2023
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
04/26/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
02/15/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/11/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/10/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/09/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/09/2022
IUAF
USE AMENDMENT FILED
12/17/2021
EISU
TEAS STATEMENT OF USE RECEIVED
12/17/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/22/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/27/2021
PUBO
PUBLISHED FOR OPPOSITION
04/27/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/07/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/24/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
03/24/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/24/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
03/24/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/24/2021
DOCK
ASSIGNED TO EXAMINER
03/18/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/06/2020
NWAP
NEW APPLICATION ENTERED
10/22/2020
Continuous trademark protection
Get notified about every new filing that threatens CEDLARA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.